TEMPORARY REMOVAL: A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products

Curr Probl Cardiol. 2021 Oct 1 : 101011.

Jessica Rose

1Institute of Pure and Applied Knowledge, Public Health Policy Initiative (PHPI)

Peter A. McCullough

2Truth for Health Foundation, Tucson, AZ, USA

1Institute of Pure and Applied Knowledge, Public Health Policy Initiative (PHPI)

2Truth for Health Foundation, Tucson, AZ, USA

āŽCorrespondence.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

Abstract

The Publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the article will be specified, or the article will be reinstated.

The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483988/